21 research outputs found
Seleção de caracterĂsticas morfofuncionais de cavalos da raça Mangalarga Marchador por meio da análise de componentes principais
Glucocorticoid-induced TNF receptor-triggered T cells are key modulators for survival/death of neural stem/progenitor cells induced by ischemic stroke
Increasing evidences show that immune response affects the reparative mechanisms in injured brain. Recently, we have demonstrated that CD4+T cells serve as negative modulators in neurogenesis after stroke, but the mechanistic detail remains unclear. Glucocorticoid-induced tumor necrosis factor (TNF) receptor (GITR), a multifaceted regulator of immunity belonging to the TNF receptor superfamily, is expressed on activated CD4+T cells. Herein, we show, by using a murine model of cortical infarction, that GITR triggering on CD4+T cells increases poststroke inflammation and decreases the number of neural stem/progenitor cells induced by ischemia (iNSPCs). CD4+GITR+T cells were preferentially accumulated at the postischemic cortex, and mice treated with GITR-stimulating antibody augmented poststroke inflammatory responses with enhanced apoptosis of iNSPCs. In contrast, blocking the GITR–GITR ligand (GITRL) interaction by GITR–Fc fusion protein abrogated inflammation and suppressed apoptosis of iNSPCs. Moreover, GITR-stimulated T cells caused apoptosis of the iNSPCs, and administration of GITR-stimulated T cells to poststroke severe combined immunodeficient mice significantly reduced iNSPC number compared with that of non-stimulated T cells. These observations indicate that among the CD4+T cells, GITR+CD4+T cells are major deteriorating modulators of poststroke neurogenesis. This suggests that blockade of the GITR–GITRL interaction may be a novel immune-based therapy in stroke
Análise multivariada das medidas morfométricas de potros da raça Mangalarga Marchador: análise de componentes principais
A stable human brain microvascular endothelial cell line retaining its barrier-specific nature, independent of the passage number
Objectives: The breakdown of the blood–brain barrier (BBB) has been considered to be a key step in the disease process of a number of neuroimmunological disorders. Although several in vitro BBB models derived from human tissues have been established, no human conditionally immortalized in vitro BBB models using a temperature-sensitive SV40-T antigen (tsA58) and human telomerase reverse transcriptase (hTERT) have ever been reported. In the present study, we established a new human brain microvascular endothelial cell line harboring tsA58 and hTERT genes, and extensively characterized this new model.Methods: TY08 cells, derived from the human BBB and harboring tsA58, were infected with retroviruses possessing hTERT genes. We examined whether this new model retains its barrier-specific nature, independent of the passage number.Results: The obtained endothelial cell line, termed TY09, proliferated well under the permissive temperature and stopped growing under the nonpermissive temperature, despite the acquisition of hTERT as an additional immortalizing gene. Even with a high-passage number, the cells maintained a spindle-shaped morphology, the expression of the von Willebrand factor, tight junction proteins and transporters. Furthermore, we carried out a transendothelial transport study for TY09 cells and hCMEC/D3 cells, thereby proving that both cell lines have almost the same nature with respect to transcellular permeability of various hydrophilic and hydrophobic substances.Conclusions: The new stable conditionally immortalized TY09 cells, retaining the in vivo BBB functions, should facilitate the performance of future studies for determining the pathophysiology of various neuroimmunological diseases